Soros Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Soros Fund Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-193,000	Closed	-$39.8M	–	256
2018 Q1	$39.8M	Buy	193,000 +135,500	+236%	+$28.4M	0.65%	31
2017 Q4	$10.9M	Buy	+57,500	New	+$11M	0.25%	78

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Soros Fund Management's TMO Position: Q2 2018 in Review

Soros Fund Management sold out of Thermo Fisher Scientific (TMO) in Q2 2018, closing a stake of 193,000 shares — an estimated $39.8M sold.

Soros Fund Management first reported a position in TMO in Q4 2017 and held it in 2 quarters. The position peaked at $39.8M in Q1 2018. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

Soros Fund Management reported no remaining Thermo Fisher Scientific position as of Q2 2018 after selling out during the quarter.
Soros Fund Management sold 193,000 Thermo Fisher Scientific shares in Q2 2018, an estimated $39.8M.
Soros Fund Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 2 quarters.
Soros Fund Management's Thermo Fisher Scientific position peaked at $39.8M in Q1 2018.
1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Soros Fund Management's 13F filing for Q2 2018, filed 14 Aug 2018.